MedPath

Mupirocin

MUPIROCIN OINTMENT USP, 2%1010For Dermatologic Use

Approved
Approval ID

323bcad0-1e11-4946-a151-1a33557f0bfb

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Feb 29, 2012

Manufacturers
FDA

Rebel Distributors Corp

DUNS: 118802834

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Mupirocin

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code42254-137
Application NumberANDA065085
Product Classification
M
Marketing Category
C73584
G
Generic Name
Mupirocin
Product Specifications
Route of AdministrationTOPICAL
Effective DateSeptember 17, 2009
FDA Product Classification

INGREDIENTS (3)

POLYETHYLENE GLYCOL 400Inactive
Code: B697894SGQ
Classification: IACT
POLYETHYLENE GLYCOL 3350Inactive
Code: G2M7P15E5P
Classification: IACT
MUPIROCINActive
Quantity: 20 mg in 1 g
Code: D0GX863OA5
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Mupirocin - FDA Drug Approval Details